Maoyu Li
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 12
- S100 Proteins and Annexins 12
- Ubiquitin and proteasome pathways 9
- Machine Learning in Bioinformatics 8
- Spectroscopy 20
- Advanced Proteomics Techniques and Applications 19
- Co-authors
- Yongheng Chen (23 shared papers)Zhe Cheng (2 shared papers)Raja Dey (1 shared paper)Zhuchu Chen (56 shared papers)Zhi‐Qiang Xiao (46 shared papers)Fang Peng (34 shared papers)Pengfei Zhang (28 shared papers)Hong Yi (26 shared papers)
- Journals
- Medical Oncology (5 papers)Journal of Proteome Research (5 papers)Journal of Cancer (5 papers)Journal of Cellular Biochemistry (4 papers)Electrophoresis (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Maoyu Li
108 papers receiving 3.8k citations
Maoyu Li's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 669
- Biomaterials 478
- Molecular Biology 2.0k
- Oncology 651
- Automotive Engineering 278
Countries citing papers authored by Maoyu Li
This map shows the geographic impact of Maoyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoyu Li more than expected).
Fields of papers citing papers by Maoyu Li
This network shows the impact of papers produced by Maoyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoyu Li. The network helps show where Maoyu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Maoyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanomaterials for cancer therapy: current progress and perspectives Hit paper breakdown → | 2021 | 819 |
| 2 | Nanotechnology in cancer diagnosis: progress, challenges and opportunities Hit paper breakdown → | 2019 | 341 |
| 3 | 2011 | 214 | |
| 4 | 2010 | 153 | |
| 5 | 2008 | 130 | |
| 6 | 2005 | 119 | |
| 7 | 2023 | 85 | |
| 8 | 2006 | 73 | |
| 9 | 2021 | 73 | |
| 10 | 2010 | 70 | |
| 11 | 2012 | 56 | |
| 12 | 2022 | 56 | |
| 13 | 2017 | 54 | |
| 14 | 2008 | 54 | |
| 15 | 2008 | 47 | |
| 16 | 2007 | 45 | |
| 17 | 2003 | 45 | |
| 18 | 2023 | 44 | |
| 19 | 2023 | 43 | |
| 20 | 2021 | 40 |
About Maoyu Li
Maoyu Li is a scholar working on Molecular Biology, Spectroscopy, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 111 papers that have together received 3.9k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (19 papers), RNA modifications and cancer (12 papers), S100 Proteins and Annexins (12 papers), Peptidase Inhibition and Analysis (12 papers), Evacuation and Crowd Dynamics (10 papers), Traffic and Road Safety (9 papers), Ubiquitin and proteasome pathways (9 papers) and Machine Learning in Bioinformatics (8 papers). The work is most often cited by research in Cancer Research (669 citations), Biomaterials (478 citations), Molecular Biology (2.0k citations), Oncology (651 citations) and Automotive Engineering (278 citations). Maoyu Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yongheng Chen, Zhe Cheng, Raja Dey, Zhuchu Chen, Zhi‐Qiang Xiao, Fang Peng, Pengfei Zhang, Hong Yi, Ting Liu and Ye Zhang. Their work appears in journals such as Medical Oncology, Journal of Proteome Research, Journal of Cancer, Journal of Cellular Biochemistry and Electrophoresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.